Epstein-Barr virus (EBV) infection is one of the most common viral infections in humans. Most people exposed to the virus don’t develop symptoms or only have mild symptoms. It’s the most ...

Additionally, MS and SLE patients have a dysregulated immune response towards EBV only, but, again, not towards other human herpesviruses. It is proposed that an in vivo model using a virus ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

Nearly three million people around the world have multiple sclerosis. Scientists think they have now uncovered a mystery cause of this incurable disease. It is a virus that nearly every one of us ...

The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV). The aim is to protect people from a range of serious diseases such as infectious ...

The Epstein–Barr virus (EBV), a member of the herpesvirus family, is best known for causing infectious mononucleosis, or “glandular fever.” However, in recent years, EBV has garnered ...

Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with several types of cancer and multiple sclerosis There are no current treatments or vaccines for EBV First participant ...

If successfully developed, the mRNA-1189 vaccine would be taken preemptively. “The goal is to prevent EBV in the same way that we prevent measles, mumps, rubella and chicken pox,” Senders said.

Researchers are looking at how the antiplatelet drug dipyridamole might keep the virus from becoming active again. Epstein-Barr can cause mononucleosis that can enlarge the spleen. This could ...

Future Virology. 2013;8(2):173-182. Additionally, there are reports that demonstrate that mononucleosis can induce the onset of SLE symptoms. [71–73] It is possible to speculate that ...